Pablo Antúnez-Muiños: PLATEBRISK Study – Review of Simplified Antithrombotic Regimen after LAAO
EuroIntervention shared on X:
”The PLATEBRISK study suggests that a simplified antithrombotic regimen after LAAO is as effective as conventional treatment for high bleeding risk patients, with a lower rate of major bleeding in those with a history of bleeding. Pablo Antúnez-Muiños”
Article: A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study
Authors: Pablo Antúnez-Muiños, Sergio López-Tejero, Pedro Cepas-Guillén, Matias Mon-Noboa, Juan M. Ruiz-Nodar, Luis Andrés-Lalaguna, Fernando Rivero, Juan Gabriel Córdoba-Soriano, Ignacio J. Amat-Santos, Berenice Caneiro-Queija, David Martí Sánchez, Javier Jimeno Sánchez, Fernando Torres Mezcua, Fabián Blanco-Fernández, Jorge Sanz Sánchez, Cristina Moreno-Ambroj, Rodrigo Estévez-Loureiro, Luis Nombela-Franco, Xavier Freixa-Rofastes, Ignacio Cruz-González
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy